Demonstrably effective cancer management must be primarily adjudicated by a singular metric: Overall Survivorship.
Hence, those therapies which contribute in a statistically substantive manner to a material extension in Overall Survivorship beyond what the Standard of Care alone can provide, become candidate additions to a strategically cogent disease management protocol.
Since 1996, control of glucose and ketone metabolism as an adjuvant to the Standard of Care, has repeatedly demonstrated its capacity to extend Overall Survivorship, well beyond what the Standard of Care alone can provide, as elucidated by Kaplan-Meier survivorship curves.
Importantly, metabolic therapy can be used both with, and without, the Standard of Care:
Direct comparison between Glioblastoma patients who include metabolic therapies alongside the Standard of Care, to those who do not, demonstrates a dramatic disparity in Overall Survivorship:
The practical application of Press/Pulse protocol does require a cogent clinical framework, as demonstrated here:
This particular publication demonstrates that glucose and ketone control, when paired with the immunotherapy drugs Ipilimumab and Nivolumab, can lead to compelling control of disease:
https://www.sustainableinterventions.org/s/Combining-a-Ketogenic-Diet-with-Chemoimmunotherapy.pdf
Here, we learn about two pediatric astrocytoma cases, which successfully applied metabolic control to degrade disease progression, in a uniformly fatal tumor model, extending survivorship, significantly:
https://www.sustainableinterventions.org/s/ketogenic_diet_case_study_two_pediatric_patients.pdf
Immaterial of tumor model or tissue of origin, one can readily ascertain the effects of metabolic therapy on, in this particular instance, prostate cancer:
https://www.sustainableinterventions.org/s/The_Effects_Of_Diet_On_Prostate_Cancer.pdf
Here, Central Nervous System Malignancies are addressed using metabolic control of tumor metabolism:
One can ascertain the effects of metabolic control as pertains to lung and pancreatic cancer, here:
Breast Cancer can be successfully managed with complementary metabolic therapy:
Lung cancer can be competently addressed with metabolic therapies: